Liposomal formulations of photosensitizers

S Ghosh, KA Carter, JF Lovell - Biomaterials, 2019‏ - Elsevier
Photodynamic therapy (PDT) is a clinical ablation modality to treat cancers and other
diseases. PDT involves administration of a photosensitizer, followed by irradiation of target …

The Photosensitizer Temoporfin (mTHPC) – Chemical, Pre‐clinical and Clinical Developments in the Last Decade

A Wiehe, MO Senge - Photochemistry and Photobiology, 2023‏ - Wiley Online Library
This review follows the research, development and clinical applications of the
photosensitizer 5, 10, 15, 20‐tetra (m‐hydroxyphenyl) chlorin (m THPC, temoporfin) in …

Current state of the nanoscale delivery systems for temoporfin-based photodynamic therapy: Advanced delivery strategies

I Yakavets, M Millard, V Zorin, HP Lassalle… - Journal of Controlled …, 2019‏ - Elsevier
Enthusiasm for photodynamic therapy (PDT) as a promising technique to eradicate various
cancers has increased exponentially in recent decades. The majority of clinically approved …

Bioluminescence resonance energy transfer using luciferase-immobilized quantum dots for self-illuminated photodynamic therapy

CY Hsu, CW Chen, HP Yu, YF Lin, PS Lai - Biomaterials, 2013‏ - Elsevier
Photodynamic therapy (PDT) is an innovative method for cancer treatment that involves the
administration of a photosensitizing agent followed by exposure to visible light. An …

Improved in vivo delivery of m-THPC via pegylated liposomes for use in photodynamic therapy

MJ Bovis, JH Woodhams, M Loizidou… - Journal of Controlled …, 2012‏ - Elsevier
Pegylated liposomal nanocarriers have been developed with the aim of achieving improved
uptake of the clinical PDT photosensitiser, m-THPC, into target tissues through increased …

Strategies for optimizing the delivery to tumors of macrocyclic photosensitizers used in photodynamic therapy (PDT)

F Moret, E Reddi - Journal of Porphyrins and Phthalocyanines, 2017‏ - World Scientific
This review briefly summaries the principles and mechanisms of action of photodynamic
therapy (PDT) as concerns its application in the oncological field, highlighting its drawbacks …

Current status of liposomal porphyrinoid photosensitizers

P Skupin-Mrugalska, J Piskorz, T Goslinski… - Drug discovery today, 2013‏ - Elsevier
Highlights•Liposomes as highly potent carriers for porphyrinoid photosensitizer
delivery.•Visudyne®–the first commercially available liposomal photosensitizer.• …

Porphyrin Macrocycles: General Properties and Theranostic Potential

R Boscencu, N Radulea, G Manda, IF Machado… - Molecules, 2023‏ - mdpi.com
Despite specialists' efforts to find the best solutions for cancer diagnosis and therapy, this
pathology remains the biggest health threat in the world. Global statistics concerning deaths …

[HTML][HTML] Uptake and photo-toxicity of Foscan®, Foslip® and Fospeg® in multicellular tumor spheroids

E Gaio, D Scheglmann, E Reddi, F Moret - Journal of Photochemistry and …, 2016‏ - Elsevier
In cancer photodynamic therapy (PDT), an efficient and homogeneous intratumoral
accumulation of the photosensitizer (PS) is required to induce cell damages in the entire …

Photodynamic and antiangiogenic activities of parietin liposomes in triple negative breast cancer

AM Ayoub, MU Amin, G Ambreen, AA Dayyih… - Biomaterials …, 2022‏ - Elsevier
Parietin (PTN) is an anthraquinone with promising efficacy in the inhibition of cancer cell
proliferation and tumor growth. Due to its hydrophobicity, PTN is sparingly soluble under …